# Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

> **NCT06833229** · — · RECRUITING · sponsor: **Centre Antoine Lacassagne** · enrollment: 200 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung (NSCLC)

## Interventions

- **PROCEDURE:** FDG-PET

## Key facts

- **NCT ID:** NCT06833229
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-27
- **Primary completion:** 2028-05-27
- **Final completion:** 2031-01-27
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833229, "Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06833229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*